San Diego-based mostly Viking Therapeutics marked itself as a serious competitor within the weight loss drug marketplace in February just after revealing promising information from a mid-stage trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when offered to be a weekly injection As well as in M